Latham & Watkins LLP represented Summit Partners in the transaction. Ropes & Gray represented 48forty Solutions and Audax Private Equity. Latham & Watkins also represented Antares...
Summit Partners’ Investment in 48forty Solutions
Chevron’s $3.15 Billion Acquisition of Renewable Energy Group
Paul, Weiss, Rifkind, Wharton & Garrison and Shearman & Sterling represented Chevron, while Latham & Watkins represented Renewable Energy Group in the transaction. Chevron Corporation (NYSE: CVX)...
Monster Beverage Corporation’s $330 Million Acquisition of CANarchy
Jones Day advised Monster Beverage Corporation on the deal, while Latham & Watkins represented CANarchy Craft Brewery Collective. Monster Beverage Corporation announced the $330 million acquisition of CANarchy...
Oracle’s $28.3 Billion Acquisition of Cerner
Latham & Watkins represented Cerner in the transaction. Hogan Lovells advised Oracle Corporation. Fried Frank acted as counsel to Goldman Sachs and Centerview Partners as financial...
P3 Health Partners’ Business Combination with Foresight Acquisition Corp.
Latham & Watkins represented P3 Health Partners in the transaction. P3 Health Partners, a patient-centered and physician-led population health management company, has closed its previously announced business combination...
Winc’s Initial Public Offering
Latham & Watkins represented Winc, Inc. in the offering. Manatt Represents Spartan Capital Securities LLC and Revere Securities LLC. Winc, Inc., one of the fastest growing at...
Waldencast’s $1.2 Billion Business Combination With Obagi and Milk Makeup
Skadden, Arps, Slate, Meagher & Flom represented Waldencast. Latham & Watkins, working alongside Conyers and Nixon Peabody, represented Obagi, and Goodwin Procter represented Milk Makeup in...
Minerva Surgical’s $75 Million Initial Public Offering
Latham & Watkins represented the underwriters in the transaction. Minerva Surgical, Inc. (Minerva Surgical), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB),...
Procept BioRobotics’ $163.9 Million Initial Public Offering
Latham & Watkins represented PROCEPT in the transaction. PROCEPT BioRobotics Corporation, a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology,...
Aspiration’s Merger With InterPrivate III Financial Partners
Latham & Watkins represented Aspiration, while White & Case represented InterPrivate III in the transaction. Sidley Austin acted as legal advisor to the placement agents. Aspiration Partners,...
Ginger’s Merger with Headspace
Wilson Sonsini Goodrich & Rosati advised Ginger on the deal, while Latham & Watkins represented Headspace. Ginger, a leading provider of on-demand mental healthcare, and Headspace, a...
Traeger’s $487 Million Initial Public Offering
Latham & Watkins LLP represented Traeger, while Fried Frank acted as counsel to Morgan Stanley & Co. LLC, as representative of the underwriters, in the IPO....